C07D223/28 - CPC Classification Index

ClassID:

94343 ⎘

C07D223/28 - CPC Classification

Classification description:

Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Dibenzazepines; Hydrogenated dibenzazepines; Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Recent Application in this class:

20240228432

2024-07-11

Sirtuin modulating compounds and applications thereof

20240228431

2024-07-11

SIRTUIN MODULATING COMPOUNDS AND APPLICATIONS THEREOF

20230174485

2023-06-08

LIPOXYGENASE INHIBITORS

20230020161

2023-01-19

Tricyclic Modulators of PP2A

20220339163

2022-10-27

HECT E3 LIGASE INHIBITORS AND USES THEREOF

20200317620

2020-10-08

Selective inhibition of gluconeogenic activity

20170226115

2017-08-10

Selective inhibitors of constitutive androstane receptor

20170190668

2017-07-06

ASYMMETRIC CATALYTIC REDUCTION OF OXCARBAZEPINE

20170159028

2017-06-08

Biocatalytic process for preparing eslicarbazepine and analogs thereof

#10

20170015630

2017-01-19

Constrained tricyclic sulfonamides

#11

20170000801

2017-01-05

Triarylmethane analogs and their use in treating cancers

#12

20160244792

2016-08-25

Biocatalytic process for preparing eslicarbazepine and analogs thereof

#13

20160102048

2016-04-14

N-(4-(bis(4-(dimethylamino)phenyl)methylene)-8-(dimethylamino)

#14

20160090379

2016-03-31

Compositions and methods for the treatment of epilepsy and neurological disorders

#15

20150329835

2015-11-19

Biocatalytic process for preparing eslicarbazepine and analogs thereof

#16

20150328231

2015-11-19

Preventive or therapeutic agent for pain associated with herpes zoster in acute phase

#17

20150232426

2015-08-20

PROCESS FOR THE PREPARATION OF OXCARBAZEPINE AND ITS USE AS INTERMEDIATE IN THE PREPARATION OF ESLICARBAZEPINE ACETATE

#18

20150148301

2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#19

20150065704

2015-03-05

PROCESS FOR THE PREPARATION AND PURIFICATION OF ESLICARBAZEPINE ACETATE AND INTERMEDIATES THEREOF

#20

20140213578

2014-07-31

Tricyclic compounds as anticancer agents

#21

20140199735

2014-07-17

Biocatalytic process for preparing eslicarbazepine and analogs thereof

#22

20140148599

2014-05-29

Preventive or therapeutic agent for pain associated with herpes zoster in acute phase

#23

20140011988

2014-01-09

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#24

20130345198

2013-12-26

Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof

#25

20130274248

2013-10-17

Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same

#26

20130123490

2013-05-16

Process for the asymmetric transfer hydrogenation of ketones

#27

20130041146

2013-02-14

Asymmetric catalytic reduction of oxcarbazepine

#28

20120322089

2012-12-20

Sensitive and generic antibodies and multiple applications

#29

20120190847

2012-07-26

Triarylmethane analogs and their use in treating cancers

#30

20120095217

2012-04-19

FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF

#31

20120022047

2012-01-26

PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE

#32

20110263526

2011-10-27

Nitric Oxide Releasing Prodrugs of Therapeutic Agents

#33

20110196147

2011-08-11

INHIBITORS OF HISTONE DEACETYLASE

#34

20100189762

2010-07-29

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#35

20100160296

2010-06-24

Use of imipramine blue and analogs thereof in treating cancers

#36

20100045170

2010-02-25

Novel organic electroluminescent compounds and organic electroluminescent device using the same

#37

20090258859

2009-10-15

Metronidazole cocrystals and imipramine cocrystals

#38

20090203902

2009-08-13

Asymmetric catalytic reduction of oxcarbazepine

#39

20090176745

2009-07-09

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#40

20090105472

2009-04-23

Process for the preparation of (S)-(+)-10,11-dihydro-10-hydroxy-5H-dibenz (b,f)azepine-5-carboxamide

#41

20090105223

2009-04-23

Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same

#42

20090082335

2009-03-26

DEUTERIUM-ENRICHED OXCARBAZEPINE

#43

20080269480

2008-10-30

Process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide

#44

20080242698

2008-10-02

Organic Compounds

#45

20080221320

2008-09-11

Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[B,F]azepine-5-carboxyamide

#46

20080207590

2008-08-28

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#47

20080074045

2008-03-27

ORGANIC ELECTROLUMINESCENCE DEVICE

#48

20070149507

2007-06-28

Process for preparing oxcarbazepine

#49

20070073057

2007-03-29

Method for preparation of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide

#50

20070032647

2007-02-08

Novel process for preparation of 10-oxo-10, 11-dihydro-5h-dibenz [b,f] azepine-5-carbox- amide (oxcarbazepine) via intermediate, 10-methoxy-5h-debenz[b,f] azepine-5-carbonyl- chloride

#51